128 related articles for article (PubMed ID: 18359978)
1. CDH11 expression is associated with survival in patients with osteosarcoma.
Nakajima G; Patino-Garcia A; Bruheim S; Xi Y; San Julian M; Lecanda F; Sierrasesumaga L; Müller C; Fodstad O; Ju J
Cancer Genomics Proteomics; 2008; 5(1):37-42. PubMed ID: 18359978
[TBL] [Abstract][Full Text] [Related]
2. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma.
Laverdiere C; Hoang BH; Yang R; Sowers R; Qin J; Meyers PA; Huvos AG; Healey JH; Gorlick R
Clin Cancer Res; 2005 Apr; 11(7):2561-7. PubMed ID: 15814634
[TBL] [Abstract][Full Text] [Related]
3. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
4. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
[TBL] [Abstract][Full Text] [Related]
7. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
[TBL] [Abstract][Full Text] [Related]
9. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
10. The expression of CRM1 is associated with prognosis in human osteosarcoma.
Yao Y; Dong Y; Lin F; Zhao H; Shen Z; Chen P; Sun YJ; Tang LN; Zheng SE
Oncol Rep; 2009 Jan; 21(1):229-35. PubMed ID: 19082467
[TBL] [Abstract][Full Text] [Related]
11. Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity.
Look AT; Douglass EC; Meyer WH
N Engl J Med; 1988 Jun; 318(24):1567-72. PubMed ID: 3163773
[TBL] [Abstract][Full Text] [Related]
12. Expression of platelet-derived growth factor-alpha receptor in human osteosarcoma is not a predictor of outcome.
Sulzbacher I; Birner P; Dominkus M; Pichlhofer B; Mazal PR
Pathology; 2010 Dec; 42(7):664-8. PubMed ID: 21080877
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.
Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY
Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
15. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of adenomatous polyposis coli gene expression in osteosarcoma of the extremities.
Guimarães AP; Rocha RM; da Cunha IW; Guimarães GC; Carvalho AL; de Camargo B; Lopes A; Squire JA; Soares FA
Eur J Cancer; 2010 Dec; 46(18):3307-15. PubMed ID: 20594821
[TBL] [Abstract][Full Text] [Related]
17. Ezrin expression predicts survival in stage IIB osteosarcomas.
Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
[TBL] [Abstract][Full Text] [Related]
18. Tenascin-C as a prognostic biomarker in osteosarcoma?
Xiong W; Niu PY; Zhu WT; Chen J
Chin Med J (Engl); 2009 Nov; 122(22):2737-43. PubMed ID: 19951606
[TBL] [Abstract][Full Text] [Related]
19. Expression of heat shock proteins in osteosarcomas.
Moon A; Bacchini P; Bertoni F; Olvi LG; Santini-Araujo E; Kim YW; Park YK
Pathology; 2010; 42(5):421-5. PubMed ID: 20632817
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcoma.
Deng Z; Niu G; Cai L; Wei R; Zhao X
Biomed Res Int; 2013; 2013():496193. PubMed ID: 23971040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]